Standardized ketogenic diet demonstrates ‘dramatic beneficial effects’ in patients with NASH

SAN DIEGO – A weight management program based on the ketogenic diet substantially improved metabolic parameters and markers of liver disease in patients with non-alcoholic steatohepatitis, according to results presented at Digestive Disease Week.
“This study was unique because there have only been two other studies, done 5 and 10 years ago, that used the ketogenic diet in nonalcoholic fatty liver disease,” Yuliya Belopolsky, MD, a resident in internal medicine at NorthShore University Health System, told Healio Gastroenterology. “This is the first study to look at NASH.”

Source link

Related posts

Laparoscopy-Assisted vs. Balloon Enteroscopy ERCP After Gastric Bypass


Huge Cancer Bill; Mixed Data for Vitamin D; Cancer's Toll on Function


Large-scale Genome-wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World